USANA Health Sciences reported quarterly EPS of $0.61, beating the Zacks Consensus Estimate of $0.44 by $0.17, or about 38.6%. Earnings were still down from $0.73 a year ago, indicating year-over-year pressure despite the beat. The print is modestly positive for the stock but not a major market-wide catalyst.
USANA Health Sciences reported quarterly EPS of $0.61, beating the Zacks Consensus Estimate of $0.44 by $0.17, or about 38.6%. Earnings were still down from $0.73 a year ago, indicating year-over-year pressure despite the beat. The print is modestly positive for the stock but not a major market-wide catalyst.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly positive
Sentiment Score
0.25
Ticker Sentiment
